skip to Main Content

Microdissected Pancreatic Cancer Proteomes Reveal Tumor Heterogeneity and Therapeutic Targets

Microdissected Pancreatic Cancer Proteomes Reveal Tumor Heterogeneity and Therapeutic Targets
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a relative paucity of cancer cells that are surrounded by an abundance of non-tumor cells and extracellular matrix, known as stroma. The interaction between stroma and cancer cells contributes to poor outcome, but how proteins from these individual compartments drive aggressive tumor behavior is not known.

Here, we report the proteomic analysis of laser-capture microdissected (LCM) PDAC samples. We isolated stroma, tumor, and bulk samples from a cohort with long- and short-term survivors. Compartment-specific proteins were measured by mass spectrometry, yielding the largest PDAC proteome landscape to date. Read more . . . 


Back To Top